Patents by Inventor Rolf Seljelid

Rolf Seljelid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical uses of glucans
    Patent number: 8946193
    Abstract: The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: February 3, 2015
    Assignee: Biotec Pharmacon ASA
    Inventor: Rolf Seljelid
  • Methods of skin treatment and use of water-soluble ?-(1,3) glucans as active agents for producing therapeutic skin treatment agents
    Patent number: 8912165
    Abstract: A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble ?-(1,3) glucan with ?-(1,6) linked side-chains, where the side-chains comprise ?-(1,3) linkages or up to four consecutive ?-(1,6) linkages a active ingredients.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: December 16, 2014
    Assignee: Biotec Pharmacon ASA
    Inventors: Rolf Engstad, Rolf Seljelid
  • Methods of Skin Treatment and Use of Water-Soluble Beta-(1,3) Glucans as Active Agents for Producing Therapeutic Skin Treatment Agents
    Publication number: 20130296265
    Abstract: A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble ?-(1,3) glucan with ?-(1,6) linked side-chains, where the side-chains comprise ?-(1,3) linkages or up to four consecutive ?-(1,6) linkages a active ingredients.
    Type: Application
    Filed: July 2, 2013
    Publication date: November 7, 2013
    Inventors: Rolf Engstad, Rolf Seljelid
  • Methods of skin treatment and use of water-soluble ?-(1,3) glucans as active agents for producing therapeutic skin treatment agents
    Patent number: 8501710
    Abstract: A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble ?-(1,3) glucan with ?-(1,6) linked side-chains, where the side-chains comprise ?-(1,3) linkages or up to four consecutive ?-(1,6) linkages as active ingredients.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: August 6, 2013
    Assignee: Biotec Pharmacon ASA
    Inventors: Rolf Engstad, Rolf Seljelid
  • Medical Uses of Glucans
    Publication number: 20120295868
    Abstract: The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.
    Type: Application
    Filed: July 30, 2012
    Publication date: November 22, 2012
    Applicants: Mount Sinai School of Medicine of New York University, Biotec Pharmacon ASA
    Inventors: Rolf SELJELID, Xiu-Min LI
  • Medical Uses of Glucans
    Publication number: 20100322923
    Abstract: The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.
    Type: Application
    Filed: February 21, 2008
    Publication date: December 23, 2010
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Rolf Seljelid, Xiu-Min Li
  • Methods of skin treatment and use of water-soluble beta-(1,3) glucans as active agents for producing therapeutic skin treatment agents
    Publication number: 20050009781
    Abstract: A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble ?-(1,3) glucan with ?-(1,6) linked side-chains, where the side-chains comprise ?-(1,3) linkages or up to four consecutive ?-(1,6) linkages as active ingredients.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 13, 2005
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Rolf Engstad, Rolf Seljelid
  • Carbohydrates and use thereof
    Patent number: 6423832
    Abstract: The invention relates to new etherified carbohydrate derivatives, a method for production thereof, pharmaceutical compositions containing the same and use for the production of a pharmaceutical preparation for treatment of conditions in which macrophages are stimulated or down-regulated. In an embodiment of the present invention, said carbohydrate derivatives comprise general formula (I) wherein n is an integer in the range from 3 to 98, and each group R independently represents a hydrogen atom or an aliphatic, saturated or unsaturated hydrocarbon chain having from 7 to 30 carbon atoms.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: July 23, 2002
    Assignee: Biotec Pharmacon ASA
    Inventor: Rolf Seljelid
  • Macrophage-activating composition and a process for its manufacture
    Patent number: 4795745
    Abstract: Macrophage-stimulatory composition containing a water-soluble .beta.-1.3-bound glucan and a water-insoluble carrier to which the glucan has been immobilized; its use; and a process for its manufacture.
    Type: Grant
    Filed: September 19, 1985
    Date of Patent: January 3, 1989
    Inventors: Karl O. P. Larm, James Hoffman, Rolf Seljelid, Jarl Bogwald
  • Water-soluble aminated .beta.-1,3-bound D-glucan and composition containing same
    Patent number: 4707471
    Abstract: Water-soluble aminated .beta.-1,3-bound D-glucan and macrophage-stimulating composition containing as an active constituent such glucan.
    Type: Grant
    Filed: December 11, 1984
    Date of Patent: November 17, 1987
    Assignee: Medicarb AB
    Inventors: Olle Larm, Rolf Seljelid